Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Supplementation with cholecalciferol does not result in weight reduction in overweight and obese subjects.

Sneve M, Figenschau Y, Jorde R.

Eur J Endocrinol. 2008 Dec;159(6):675-84. doi: 10.1530/EJE-08-0339.

2.

A parallel group double-blind RCT of vitamin D3 assessing physical function: is the biochemical response to treatment affected by overweight and obesity?

Wood AD, Secombes KR, Thies F, Aucott LS, Black AJ, Reid DM, Mavroeidi A, Simpson WG, Fraser WD, Macdonald HM.

Osteoporos Int. 2014 Jan;25(1):305-15. doi: 10.1007/s00198-013-2473-8. Epub 2013 Aug 28.

PMID:
23982800
3.

Vitamin D3 supplementation during weight loss: a double-blind randomized controlled trial.

Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A.

Am J Clin Nutr. 2014 May;99(5):1015-25. doi: 10.3945/ajcn.113.073734. Epub 2014 Mar 12. Erratum in: Am J Clin Nutr. 2014 Oct;100(4):1213.

4.

A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women.

Salehpour A, Hosseinpanah F, Shidfar F, Vafa M, Razaghi M, Dehghani S, Hoshiarrad A, Gohari M.

Nutr J. 2012 Sep 22;11:78. doi: 10.1186/1475-2891-11-78.

5.

Vitamin D supplementation and calcium absorption during caloric restriction: a randomized double-blind trial.

Shapses SA, Sukumar D, Schneider SH, Schlussel Y, Sherrell RM, Field MP, Ambia-Sobhan H.

Am J Clin Nutr. 2013 Mar;97(3):637-45. doi: 10.3945/ajcn.112.044909. Epub 2013 Jan 30.

6.

Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome.

Asemi Z, Foroozanfard F, Hashemi T, Bahmani F, Jamilian M, Esmaillzadeh A.

Clin Nutr. 2015 Aug;34(4):586-92. doi: 10.1016/j.clnu.2014.09.015. Epub 2014 Oct 3.

PMID:
25300649
7.

Calcium plus vitamin D3 supplementation facilitated fat loss in overweight and obese college students with very-low calcium consumption: a randomized controlled trial.

Zhu W, Cai D, Wang Y, Lin N, Hu Q, Qi Y, Ma S, Amarasekara S.

Nutr J. 2013 Jan 8;12:8. doi: 10.1186/1475-2891-12-8. Erratum in: Nutr J. 2013;12:43.

8.

Vitamin D3 supplementation and body composition in persons with obesity and type 2 diabetes in the UAE: A randomized controlled double-blinded clinical trial.

Sadiya A, Ahmed SM, Carlsson M, Tesfa Y, George M, Ali SH, Siddieg HH, Abusnana S.

Clin Nutr. 2016 Feb;35(1):77-82. doi: 10.1016/j.clnu.2015.02.017. Epub 2015 Mar 24.

PMID:
25892603
9.
10.

Effect of vitamin D replacement on indexes of insulin resistance in overweight elderly individuals: a randomized controlled trial.

El-Hajj Fuleihan G, Baddoura R, Habib RH, Halaby G, Arabi A, Rahme M, Singh RJ, Kassem M, Mahfoud Z, Hoteit M, Daher RT, Kassir MF.

Am J Clin Nutr. 2016 Aug;104(2):315-23. doi: 10.3945/ajcn.116.132589. Epub 2016 Jul 13. Erratum in: Am J Clin Nutr. 2017 Apr;105(4):1021.

PMID:
27413130
11.

Insulin-like growth factor I, growth hormone, and insulin sensitivity: the effects of a one-year cholecalciferol supplementation in middle-aged overweight and obese subjects.

Kamycheva E, Berg V, Jorde R.

Endocrine. 2013 Apr;43(2):412-8. doi: 10.1007/s12020-012-9825-6. Epub 2012 Oct 30.

PMID:
23109222
12.

No significant effect on bone mineral density by high doses of vitamin D3 given to overweight subjects for one year.

Jorde R, Sneve M, Torjesen PA, Figenschau Y, Hansen JB, Grimnes G.

Nutr J. 2010 Jan 7;9:1. doi: 10.1186/1475-2891-9-1.

13.

No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year.

Jorde R, Sneve M, Torjesen P, Figenschau Y.

J Intern Med. 2010 May;267(5):462-72. doi: 10.1111/j.1365-2796.2009.02181.x. Epub 2009 Oct 19.

14.

Cholecalciferol supplementation does not influence β-cell function and insulin action in obese adolescents: a prospective double-blind randomized trial.

Javed A, Vella A, Balagopal PB, Fischer PR, Weaver AL, Piccinini F, Dalla Man C, Cobelli C, Giesler PD, Laugen JM, Kumar S.

J Nutr. 2015 Feb;145(2):284-90. doi: 10.3945/jn.114.202010. Epub 2014 Dec 17.

15.
16.

25-Hydroxycholecalciferol response to single oral cholecalciferol loading in the normal weight, overweight, and obese.

Camozzi V, Frigo AC, Zaninotto M, Sanguin F, Plebani M, Boscaro M, Schiavon L, Luisetto G.

Osteoporos Int. 2016 Aug;27(8):2593-602. doi: 10.1007/s00198-016-3574-y. Epub 2016 Mar 30.

PMID:
27026331
17.

Effect of moderate-dose vitamin D supplementation on insulin sensitivity in vitamin D-deficient non-Western immigrants in the Netherlands: a randomized placebo-controlled trial.

Oosterwerff MM, Eekhoff EM, Van Schoor NM, Boeke AJ, Nanayakkara P, Meijnen R, Knol DL, Kramer MH, Lips P.

Am J Clin Nutr. 2014 Jul;100(1):152-60. doi: 10.3945/ajcn.113.069260. Epub 2014 Jun 4.

18.

Weight reduction effects of a black soy peptide supplement in overweight and obese subjects: double blind, randomized, controlled study.

Kwak JH, Ahn CW, Park SH, Jung SU, Min BJ, Kim OY, Lee JH.

Food Funct. 2012 Oct;3(10):1019-24. Epub 2012 Jun 28.

PMID:
22739624
19.

Effects of Vitamin D3 Supplementation on Lean Mass, Muscle Strength, and Bone Mineral Density During Weight Loss: A Double-Blind Randomized Controlled Trial.

Mason C, Tapsoba JD, Duggan C, Imayama I, Wang CY, Korde L, McTiernan A.

J Am Geriatr Soc. 2016 Apr;64(4):769-78. doi: 10.1111/jgs.14049. Epub 2016 Apr 5.

20.

Impact of vitamin D supplementation during lactation on vitamin D status and body composition of mother-infant pairs: a MAVID randomized controlled trial.

Czech-Kowalska J, Latka-Grot J, Bulsiewicz D, Jaworski M, Pludowski P, Wygledowska G, Chazan B, Pawlus B, Zochowska A, Borszewska-Kornacka MK, Karczmarewicz E, Czekuc-Kryskiewicz E, Dobrzanska A.

PLoS One. 2014 Sep 18;9(9):e107708. doi: 10.1371/journal.pone.0107708. eCollection 2014.

Supplemental Content

Support Center